You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SYNER-G regimen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GM1 Gangliosidoses, GM2 Gangliosidoses, Tay-Sachs Disease Trial in Minneapolis (miglustat, Ketogenic Diet)

Terminated
Has Results
  • GM1 Gangliosidoses
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota
Mar 18, 2021

Amyotrophic Lateral Sclerosis Trial (DNL343, Matching Placebo)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Apr 24, 2023

Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

Recruiting
  • Chronic Granulomatous Disease X-linked (X-CGD)
  • Rome, Lazio, Italy
  • +1 more
Oct 27, 2022

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 11, 2022

Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in

Recruiting
  • Secondary Acute Myeloid Leukemia Evolving From MDS
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 5, 2022

Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • AML Stage, Adult
  • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
  • Xiamen, Fujian, China
    Bing Xu
Oct 29, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
May 16, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
Feb 17, 2022

Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)

Recruiting
  • Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Mar 14, 2022

Plaque Psoriasis Trial in Canada, United States (Vectical™ Ointment weekdays and Clobex® Spray weekends regimen, Clobex® Spray

Completed
Has Results
  • Plaque Psoriasis
  • Vectical™ Ointment weekdays and Clobex® Spray weekends regimen
  • Clobex® Spray morning and Vectical™ Ointment evening regimen
  • Los Angeles, California
  • +5 more
Jul 28, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Durvalumab
  • Radiation Therapy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Nov 18, 2022

HER2-positive, Locally Advanced Solid Tumor, Immunotherapy Trial in Beijing (sintilimab, Trastuzumab, S-1 plus oxaliplatin)

Not yet recruiting
  • HER2-positive
  • +6 more
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 28, 2022

Malaria Trial in Seattle (PfSPZ Vaccine, PfSPZ Challenge (7G8) for CHMI, Normal Saline)

Completed
  • Malaria
  • PfSPZ Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 15, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Follicular Lymphoma Trial in Italy (Immunochemo regimen: Rituximab-bendamustine (Arm A), Immunochemo regimen:

Recruiting
  • Follicular Lymphoma
  • Immunochemotherapy regimen: Rituximab-bendamustine (Arm A)
  • +9 more
  • Barletta, Barletta Andria Trani, Italy
  • +68 more
Oct 13, 2022

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)

Recruiting
  • Immunotherapy
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 2, 2021

DuringProgrammed Intermittent Epidural Bolus Regimen for Labor

Completed
  • Labor Pain
  • Sensory block level check
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Sep 20, 2021

Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

Recruiting
  • Myeloproliferative Neoplasms
  • Birmingham, Alabama
  • +16 more
Jan 27, 2023

GSD1 Trial in Worldwide (DTX401)

Completed
Has Results
  • GSD1
  • DTX401
  • steroid regimen
  • Farmington, Connecticut
  • +5 more
Oct 25, 2022

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022